INFUSION REACTION

Clinical trials for INFUSION REACTION explained in plain language.

Never miss a new study

Get alerted when new INFUSION REACTION trials appear

Sign up with your email to follow new studies for INFUSION REACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

New strategy aims to tame treatment side effects in lung cancer patients

Symptom relief Not yet recruiting

This study tests a special care plan to help Chinese patients with advanced EGFR-mutated lung cancer who are taking the drug amivantamab. The plan focuses on preventing common side effects like blood clots, skin rashes, and infusion reactions. About 122 adults will join to see if…

Matched conditions: INFUSION REACTION

Phase: PHASE4 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Symptom relief

Last updated Jun 27, 2026 11:00 UTC

INFUSION REACTION

Get alerted when new INFUSION REACTION trials appear

New strategy aims to tame treatment side effects in lung cancer patients